PLCB4: Phospholipase C Beta 4

A key enzyme in phosphoinositide signaling, associated with uveal melanoma and developmental disorders.

Gene Information Card

Symbol PLCB4
Full Name Phospholipase C Beta 4
Gene Type Protein coding
Chromosomal Location 20p12.3-p12.2
NCBI Gene ID 5332 ncbi.nlm.nih.gov/gene/5332
Ensembl ID ENSG00000101333
UniProt ID Q15147
OMIM ID 600810
HGNC ID 9059
Aliases PLC-beta-4, PI-PLC, PLCB4A, PLCB4B

Description

PLCB4 encodes phospholipase C beta 4, an enzyme that hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). It is activated by G-protein alpha subunits (Gq/11) and plays a critical role in intracellular calcium signaling and cell proliferation. Mutations in PLCB4 are recurrent in uveal melanoma and cause auriculocondylar syndrome.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Uveal melanoma Activating mutations (e.g., D630Y) in the catalytic domain lead to constitutive activation of the PLC pathway, promoting tumorigenesis via MAPK and YAP signaling. PMID: 23583978, COSMIC
Auriculocondylar syndrome (ARCND) Loss-of-function or dominant-negative mutations disrupt G-protein signaling during craniofacial development, resulting in mandibular hypoplasia and ear malformations. PMID: 22581970, OMIM #614669
Isolated microtia Heterozygous missense variants in PLCB4 are associated with isolated ear malformations. PMID: 28492532

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Retina 8.2 Medium
Heart 4.1 Low
Liver 1.3 Not detected
Kidney 3.0 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 6.8 Moderate expression
SK-MEL-28 (melanoma) 9.5 High expression
MCF7 2.1 Low expression
HepG2 1.5 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
D630Y Missense Recurrent in uveal melanoma (5-10%) Gain-of-function; constitutive activation
E574K Missense Rare in uveal melanoma Gain-of-function
R621H Missense Germline in ARCND Loss-of-function/dominant-negative
S493L Missense Germline in ARCND Loss-of-function
Mutation functional classification

Loss of Function (LOF)

Germline missense variants (e.g., R621H, S493L) reduce catalytic activity or disrupt G-protein coupling, leading to auriculocondylar syndrome.

Gain of Function (GOF)

Somatic missense mutations (e.g., D630Y, E574K) in the catalytic domain increase PIP2 hydrolysis, driving uveal melanoma.

Dominant Negative (DN)

Some ARCND mutations (e.g., R621H) may interfere with wild-type PLCB4 dimerization or signaling.

Gene Ontology (GO)

• GO:0004435 - phosphatidylinositol phospholipase C activity • GO:0004871 - signal transducer activity
• GO:0005509 - calcium ion binding • GO:0006629 - lipid metabolic process
• GO:0007165 - signal transduction • GO:0016020 - membrane

Pathways

Phospholipase C beta signaling (Reactome: R-HSA-112043)
G alpha (q) signaling events (Reactome: R-HSA-416476)
GPCR downstream signaling (KEGG: hsa04020)

Protein Summary

PLCB4 is a 1,176-amino-acid protein containing a pleckstrin homology (PH) domain, four EF-hand motifs, a catalytic TIM barrel domain, and a C-terminal C2 domain. It is membrane-associated and activated by Gq/11 subunits. The protein is highly expressed in the brain and retina. Structural mutations in the catalytic domain are oncogenic in uveal melanoma, while loss-of-function variants cause craniofacial developmental defects.

Related Products

Product name Cat.No. Species Gene ID
PLCB4 Knockout HEK293 Cell Line EDJ-KQ322 Human 5332 Details Get a Quote
PLCB4 Knockout A-549 Cell Line EDJ-KQ18472 Human 5332 Details Get a Quote
PLCB4 Knockout HCT 116 Cell Line EDJ-KQ18473 Human 5332 Details Get a Quote
PLCB4 Knockout HeLa Cell Line EDJ-KQ18474 Human 5332 Details Get a Quote
PLCB4 Knockout HAP1 Cell Line EDC08134 Human 5332 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: